BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9131284)

  • 1. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study.
    Kertes PJ; Britton WA; Leonard BC
    Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of choroidal neovascularization in age-related macular degeneration with interferon alpha-2a: a short term, nonrandomized pilot study.
    Thoelen A; Menozzi M; Huber C; Messmer E
    Ger J Ophthalmol; 1995 May; 4(3):137-43. PubMed ID: 7545047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group.
    Arch Ophthalmol; 1997 Jul; 115(7):865-72. PubMed ID: 9230826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation.
    Engler CB; Sander B; Koefoed P; Larsen M; Vinding T; Lund-Andersen H
    Acta Ophthalmol (Copenh); 1993 Feb; 71(1):27-31. PubMed ID: 7682747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha-2a in the treatment of exudative senile macular degeneration.
    Jaakkola A; Anttila PM; Immonen I
    Acta Ophthalmol (Copenh); 1994 Oct; 72(5):545-9. PubMed ID: 7534027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.
    Kirkpatrick JN; Dick AD; Forrester JV
    Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern-reversal electroretinographic acuity in untreated eyes with subfoveal neovascular membranes.
    Birch DG; Anderson JL; Fish GE; Jost BF
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2097-104. PubMed ID: 1376721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The peril of the pilot study.
    Ferris FL; Murphy RP
    Arch Ophthalmol; 1996 Dec; 114(12):1506-7. PubMed ID: 8953984
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic radiation therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Holz FG; Engenhart R; Bellmann C; Debus J; Völcker HE
    Front Radiat Ther Oncol; 1997; 30():238-46. PubMed ID: 9205906
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation therapy for age-related subfoveal choroidal neovascular membranes. A pilot study.
    Bergink GJ; Deutman AF; van den Broek JE; van Daal WA; van der Maazen RM
    Doc Ophthalmol; 1995; 90(1):67-74. PubMed ID: 8549245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration.
    Jaakkola A; Heikkonen J; Tommila P; Laatikainen L; Immonen I
    Graefes Arch Clin Exp Ophthalmol; 1998 Jan; 236(1):24-30. PubMed ID: 9457513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration.
    Poliner LS; Tornambe PE; Michelson PE; Heitzmann JG
    Ophthalmology; 1993 Sep; 100(9):1417-24. PubMed ID: 8371932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a.
    Loughnan MS; Heriot WJ; O'Day J
    Aust N Z J Ophthalmol; 1992 Aug; 20(3):173-5. PubMed ID: 1280447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult choroidal neovascularization. Influence on visual outcome in patients with age-related macular degeneration. Macular Photocoagulation Study Group.
    Arch Ophthalmol; 1996 Apr; 114(4):400-12. PubMed ID: 8602776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual acuity and scar size in eyes with age-related subfoveal choroidal neovascular lesions, 30 months after radiation therapy.
    Bergnik GJ; Hoyng CB; van der Maazen RW; Deutman AF; van Daal WA
    Doc Ophthalmol; 1996-1997; 92(1):61-75. PubMed ID: 9181334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alfa-2a in the treatment of subfoveal choroidal neovascularization.
    Thomas MA; Ibanez HE
    Am J Ophthalmol; 1993 May; 115(5):563-8. PubMed ID: 7683842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Shiraga F; Ojima Y; Matsuo T; Takasu I; Matsuo N
    Ophthalmology; 1998 Apr; 105(4):662-9. PubMed ID: 9544641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration.
    Sandberg MA; Weiner A; Miller S; Gaudio AR
    Ophthalmology; 1998 Mar; 105(3):441-7. PubMed ID: 9499774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. We are very spoiled.
    Fine SL; Maguire MG
    Arch Ophthalmol; 1997 Jul; 115(7):915-6. PubMed ID: 9230835
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual results after submacular surgery for neovascularization in age-related macular degeneration.
    Roth DB; Downie AA; Charles ST
    Ophthalmic Surg Lasers; 1997 Nov; 28(11):920-5. PubMed ID: 9387179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.